Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05988957 · ClinicalTrials.gov registry record

Nutrition-Focused Approach During CGM Initiation: A Qualitative Study

A clinical trial of Type 2 Diabetes, sponsored by HealthPartners Institute.

Completed
Registry status
15
Enrollment target
1
Study location

NCT05988957: Completed study of Type 2 Diabetes, sponsored by HealthPartners Institute.

NCT05988957 is a study of Type 2 Diabetes that has completed, run by HealthPartners Institute. The registered enrollment target is 15 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05988957, a study of Type 2 Diabetes, has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of the qualitative research is to provide a deeper understanding of the perspectives of people with type 2 diabetes (T2D) who received a nutrition-focused approach (NFA) when initiating continuous glucose monitor (CGM).

Conditions Studied

Interventions

  • OTHER Semi-structured interviews using an IRB-approved interview guide

Study Locations (1)

Minnesota

  • HealthPartners Institute dba International Diabetes Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-08-01
Est. Completion 2024-03-22

Sponsor

HealthPartners Institute

146 total trials

What the Registry Record Tells You About NCT05988957

The ClinicalTrials.gov registry entry for NCT05988957 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Semi-structured interviews using an IRB-approved interview guide is the first listed.

NCT05988957 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05988957 about?

NCT05988957 is a clinical study titled "Nutrition-Focused Approach During CGM Initiation: A Qualitative Study". The purpose of the qualitative research is to provide a deeper understanding of the perspectives of people with type 2 diabetes (T2D) who received a nutrition-focused approach (NFA) when initiating continuous glucose monitor (CGM).

What is the current status of trial NCT05988957?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2023-08-01. Estimated completion is 2024-03-22.

What conditions does trial NCT05988957 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05988957?

The interventions under investigation include: Semi-structured interviews using an IRB-approved interview guide (OTHER).

Who is sponsoring clinical trial NCT05988957?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05988957 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.